Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
Dätwyler share falls after disappointing half-year figures
Dätwyler published half-year figures for 2026 that fell short of market expectations and triggered a drop in the share price. The stock fell intraday to 141 CHF and closed at 142.8 CHF, pressured by selling. Management targets such as an EBIT margin above 17% and higher organic growth are seen as ambitious, while the strong Swiss franc depresses reported revenues. Investors will watch for updated forecasts or management comments on achieving the margin and growth targets. » Altro su de.investing.com
Dätwyler appoints new chief operating officer for healthcare
Dätwyler has appointed a new chief operating officer for its healthcare business. The appointment is intended to take over the division's operational leadership and drive forward strategic tasks. » Altro su finanzen.net
Dätwyler pays dividend of CHF 3.20 for 2025
Dätwyler decided at the annual general meeting on a dividend of CHF 3.20 per share for the 2025 financial year; a total of CHF 54.40 million will be distributed. The payout therefore remains unchanged from the previous year, while the dividend yield falls to 1.96% (previously 2.40%). The dividend will be deducted on the ex-dividend date; FactSet estimates an increase to CHF 3.23 and a yield of 2.16% for 2026. » Altro su finanzen.net
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 631,27 Mln | - |
| Utile lordo | 155,68 Mln | - |
| Utile netto | 42,58 Mln | - |
| EBITDA | 109,96 Mln | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 2,43 Mld € |
Numero di azioni | 17 Mln |
Massimo/minimo a 52 settimane | 182,97 € - 139,68 € |
Rendimento da dividendo | 2,60% |
Dividendi TTM | 3,50 € |
Beta | 1,11 |
Rapporto P/E | 27,78 |
Rapporto PEG | 0,16 |
Rapporto P/B | 6,99 |
Rapporto P/S | 2,04 |
Profilo aziendale
Die Dätwyler Holding AG produziert und vertreibt Elastomerkomponenten für das Gesundheitswesen, die Mobilität, die Öl- und Gasindustrie sowie die Nahrungsmittel- und Getränkeindustrie in Europa, Nordamerika, Südamerika und Asien. Sie ist in den Segmenten Healthcare Solutions und Industrial Solutions tätig. Das Segment Healthcare Solutions bietet Gummikomponenten für vorgefüllte Spritzen, Pens und Injektionssysteme, Komponenten und Verschlüsse für injizierbare Medikamente in Fläschchen sowie Gummikomponenten für Blutentnahmesysteme, IV-Verabreichungssets, Einwegspritzen, diagnostische und medizinische Geräte usw. Die Produkte des Segments Industrial Solutions umfassen Elektromobilitätslösungen, aktive Assistenz- und Sicherheitssysteme, Bremssysteme, Kraftstoff- und Motormanagement, Abgasnachbehandlung und Dichtungskomponenten für vorgelagerte Systeme, Elektrowerkzeuge, Wasser- und Prozessindustrie. Das Unternehmen wurde 1915 gegründet und hat seinen Sitz in Altdorf, Schweiz. Die Dätwyler Holding AG ist eine Tochtergesellschaft der Pema Holding AG.
| Nome | Daetwyler Holdings |
| CEO | Volker Cwielong |
| Sede centrale | Altdorf,
ur Svizzera |
| Sito web | |
| Settore | Industria |
| Industria | Conglomerati industriali |
| Quotazione in borsa | 16/05/1995 |
| Dipendenti | 7823 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
SIX | DAE.SW |
London | 0QNJ.L |
Scopri gli asset
Gli azionisti di Daetwyler Holdings investono anche nei seguenti asset
